US Bancorp \de\
Market Movers (8-K)
NYSE
U.S. Bancorp announced record net revenue of $7.7 billion and a 22% year-over-year increase in diluted EPS to $1.35 for the second quarter of 2026.
NYSE
U.S. Bancorp maintains a 2.6% Stress Capital Buffer and plans a 3.8% increase in its quarterly common stock dividend.
NYSE
U.S. Bancorp shareholders re-elected all twelve director nominees and approved executive compensation and auditor selection at the 2026 annual meeting.
NYSE
U.S. Bancorp delivered a 15% year-over-year increase in diluted earnings per share to $1.18 for the first quarter of 2026, driven by robust loan growth and fee revenue momentum.
NYSE
U.S. Bancorp announces changes to its Consolidated Statement of Income and Balance Sheet presentation effective January 1, 2026, with no impact on historical financial performance.
NYSE
U.S. Bancorp's Board adopted a new Executive Change in Control Severance Plan to align executive benefits with peer practices and protect the company.
Quarterly Earnings (10-Q)
NYSE
U.S. Bancorp announced a 13.8% increase in net income attributable to the company for the first quarter of 2026, reaching $1.9 billion, driven by growth in net interest and noninterest income.
NYSE
U.S. Bancorp announced a significant increase in net income and diluted EPS for the third quarter and first nine months of 2025, driven by higher net revenue and improved credit quality.
Better than expected
NYSE
U.S. Bancorp announced a significant increase in net income and diluted earnings per share for the second quarter and first half of 2025, driven by revenue growth and reduced credit loss provisions.
Better than expected
Capital raise
NYSE
U.S. Bancorp's Q1 2025 net income attributable to the company rose to $1.7 billion, or $1.03 per diluted common share, driven by revenue growth and effective expense management.
Better than expected
NYSE
U.S. Bancorp's third-quarter earnings per share increased by 13.2% year-over-year, reaching $1.03, despite a 2.4% decrease in total net revenue.
Worse than expected
NYSE
U.S. Bancorp's second quarter 2024 net income attributable to U.S. Bancorp increased by 17.8% compared to the same period last year, reaching $1.6 billion.
Worse than expected
Annual Reports (10-K)
NYSE
U.S. Bancorp reports significant earnings growth, robust capital, and strategic acquisition plans for 2025, alongside detailed regulatory and risk disclosures.
Better than expected
Capital raise
NYSE
U.S. Bancorp's 2024 annual report reveals a rise in net income to $6.3 billion, driven by fee revenue growth and expense management, despite a decrease in net interest income.
NYSE
U.S. Bancorp outlines the details of its common and preferred stock, as well as its medium-term notes, in a recent SEC filing.
Insider Trading (Form 4)
NYSE
James L Chosy, Senior EVP and General Counsel of Us Bancorp \De\, sold 22,968 shares of common stock on July 23, 2026 for $63.28 per share.
NYSE
James L Chosy, Senior EVP and General Counsel of Us Bancorp \De\, reported a transaction in 3,969 shares of common stock on July 21, 2026.
NYSE
Stephen L Philipson, Vice Chair of Us Bancorp \De\, sold 36,906 shares of common stock on July 20, 2026 for $63.08 per share.
NYSE
Dilip Venkatachari, SEVP & Chief Info & Tech Officer at US Bancorp, reported a transaction involving common stock.
NYSE
Director Richard P. McKenney acquired 5,915 units of U.S. Bancorp equity through deferred compensation and restricted stock grants.
NYSE
Director Roland A. Hernandez acquired deferred compensation units and restricted stock units as part of board compensation.
Proxy Statements (Def-14A)
NYSE
U.S. Bancorp has updated its proxy statement for the upcoming annual meeting due to a director's resignation for health reasons and subsequent board adjustments.
NYSE
U.S. Bancorp announces its annual shareholder meeting to be held virtually on April 15, 2025, outlining key proposals for voting, including the election of directors, executive compensation, and auditor ratification.
NYSE
U.S. Bancorp's proxy statement reveals Gunjan Kedia will succeed Andrew Cecere as CEO in April 2025, marking a significant leadership transition for the financial institution.
NYSE
DEFA14A: U.S. Bancorp Sets Date for 2024 Annual Meeting, Outlines Key Proposals for Shareholder Vote
U.S. Bancorp's annual meeting is scheduled for April 16, 2024, with shareholders being asked to vote on director elections, executive compensation, auditor ratification, and a new stock incentive plan.
NYSE
U.S. Bancorp's proxy statement highlights key proposals for the annual shareholder meeting, including the election of directors, executive compensation, auditor ratification, and approval of the 2024 Stock Incentive Plan.
Institutional Holdings (13F)
NYSE
US Bancorp's latest 13F-HR filing reveals its institutional investment managers' equity holdings totaling over $85 billion as of December 31, 2025.
NYSE
US Bancorp has filed its quarterly 13F-HR report, revealing an aggregate equity portfolio value of over $84 billion across 9,529 positions as of September 30, 2025.
NYSE
US Bancorp and its affiliated investment managers have filed their quarterly Form 13F-HR, revealing a substantial portfolio valued at over $79.4 billion as of June 30, 2025.
NYSE
US Bancorp's latest 13F filing details its holdings as of March 31, 2025, with a total portfolio value of approximately $74.85 billion across 10,035 entries.
NYSE
US Bancorp's latest 13F filing discloses its holdings as of December 31, 2024, showcasing a diverse portfolio with a total value exceeding $76 billion.
NYSE
US Bancorp's latest 13F filing discloses its holdings as of September 30, 2024, showcasing a diverse investment portfolio across various sectors.
Schedule 13G - Passive Investments
NYSE
Vanguard Capital Management has filed a Schedule 13G reporting a 7.52% beneficial ownership stake in US Bancorp.
NYSE
The Vanguard Group has reported a 0% beneficial ownership in US Bancorp common stock following an internal realignment that disaggregated reporting responsibilities.